Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Seminoma 2 Ovarian Neoplasms 2 Neoplasms, Germ Cell and Embryonal 2 Hodgkin Disease 2 Vulvar Neoplasms 1 Testicular Neoplasms 1 Teratoma 1 Skin Neoplasms 1 Ovarian Germ Cell Cancer 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Gynecological Cancers 1 Endodermal Sinus Tumor 1 Carcinoma, Embryonal 1

Interventions

pembrolizumab 2 lenvatinib 2 aldesleukin 2 Paclitaxel 2 Cisplatin 2 Carboplatin 2 Adoptive Transfer 2 trastuzumab deruxtecan 1 liposomal doxorubicin 1 fludarabine 1 dostarlimab 1 belzutifan 1 Vaccines, Synthetic 1 Therapeutic Touch 1 Taxes 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Specimen Handling 1 Radiation 1 Practice Guidelines as Topic 1 Platinum 1 Papillomavirus Vaccines 1 Nivolumab 1 Nelfinavir 1 Imiquimod 1 Hysterectomy 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Heavy Ion Radiotherapy 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Vulvar Neoplasms × Bleomycin × Clear all

NCT05395962 2022-05-27

Elechtra

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase 2 Recruiting

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡